HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.

Abstract
We conducted a retrospective investigation of renal outcome in 329 patients with immunoglobulin A (IgA) nephropathy with an observation period longer than 36 months (82.3 +/- 38.2 months) in our renal unit between 1977 and 1995. Clinical remission, renal progression, and the impact of covariates were estimated by Kaplan-Meier analysis and a Cox regression model. In 157 of 329 patients (48%), disappearance of urinary abnormalities (clinical remission) was obtained. None of these 157 patients showed progressive deterioration, defined as a 50% increase in serum creatinine (Scr) level from baseline, during the observation period. Conversely, in patients without clinical remission, the Kaplan-Meier estimate of probability of progressive deterioration was 21% +/- 5% at 10 years. In the multivariate Cox regression model with 13 independent covariates, initial Scr level, histological score, tonsillectomy, and high-dose methylprednisolone therapy had a significant impact on clinical remission, whereas proteinuria, age, sex, levels of hematuria, blood pressure, conventional steroid therapy, angiotensin-converting enzyme inhibitor therapy, and cyclophosphamide therapy had no significant effect. These findings indicate that interventions aimed at achieving clinical remission have provided encouraging results applicable to managing patients with IgA nephropathy.
AuthorsO Hotta, M Miyazaki, T Furuta, S Tomioka, S Chiba, I Horigome, K Abe, Y Taguma
JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 38 Issue 4 Pg. 736-43 (Oct 2001) ISSN: 1523-6838 [Electronic] United States
PMID11576876 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Methylprednisolone
Topics
  • Adolescent
  • Adult
  • Anti-Inflammatory Agents (therapeutic use)
  • Cyclophosphamide (therapeutic use)
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Glomerulonephritis, IGA (complications, therapy)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Kidney Failure, Chronic (etiology)
  • Male
  • Methylprednisolone (therapeutic use)
  • Middle Aged
  • Proportional Hazards Models
  • Remission Induction
  • Retrospective Studies
  • Tonsillectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: